SERB is a European specialty pharmaceutical group focused on prescription medicines which address rare and life-threatening diseases.
Following strategic acquisitions and targeted developments, SERB has succeeded in establishing a consistent drugs portfolio focused on niche specialty pharmaceuticals to ensure continuous availability of life-saving medicines and answer unmet medical needs.
Our commitment is to continue to offer essential drugs meeting Public Health needs.